Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis. (2023)

First Author: John BV
Attributed to:  Regenerative medicine applications of cholangiocyte organoids funded by FLF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/joim.13630

PubMed Identifier: 37018129

Publication URI: http://europepmc.org/abstract/MED/37018129

Type: Journal Article/Review

Volume: 293

Parent Publication: Journal of internal medicine

Issue: 5

ISSN: 0954-6820